GPR37 promotes cancer growth by binding to CDK6 and represents a new theranostic target in lung adenocarcinoma

GPR37 promotes cancer growth by binding to CDK6 and represents a new theranostic target in lung adenocarcinoma

Lung adenocarcinoma (LUAD) is associated with poor prognosis. Identifying novel cancer targets and helpful therapeutic strategies remains a serious clinical challenge. This study detected differentially expressed genes in The Cancer Genome Atlas (TCGA) LUAD data collection. We also identified a pred...

Full description

Bibliographic Details
Main Authors: Xiaona Xie, Xueding Cai, Feng Zhou, Yaozhe Li, Qianzi Liu, Luqiong Cai, Wenjing Zhu, Jinqiu Wei, Chenying Jin, Zitian Liu, Chunhui Jiang, Haiyang Zhao, Lehe Yang, Chengguang Zhao, Xiaoying Huang
Format: Article
Language:English
Published: Elsevier 2022-09-01
Series:Pharmacological Research
Subjects:
GPR37
CDK6
LUAD
Hypocrellin B
An inhibitor
Online Access:http://www.sciencedirect.com/science/article/pii/S1043661822003346

Internet

http://www.sciencedirect.com/science/article/pii/S1043661822003346

Similar Items